DK0572190T3 - Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens - Google Patents

Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens

Info

Publication number
DK0572190T3
DK0572190T3 DK93303985T DK93303985T DK0572190T3 DK 0572190 T3 DK0572190 T3 DK 0572190T3 DK 93303985 T DK93303985 T DK 93303985T DK 93303985 T DK93303985 T DK 93303985T DK 0572190 T3 DK0572190 T3 DK 0572190T3
Authority
DK
Denmark
Prior art keywords
ester
active ingredient
containing vitamin
preparations containing
ophthalmic preparations
Prior art date
Application number
DK93303985T
Other languages
Danish (da)
English (en)
Inventor
Yoichi Kawashima
Mitsuaki Kuwano
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK0572190T3 publication Critical patent/DK0572190T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93303985T 1992-05-26 1993-05-21 Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens DK0572190T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13319392 1992-05-26

Publications (1)

Publication Number Publication Date
DK0572190T3 true DK0572190T3 (da) 1999-02-22

Family

ID=15098888

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93303985T DK0572190T3 (da) 1992-05-26 1993-05-21 Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens

Country Status (11)

Country Link
US (1) US5559157A (pt)
EP (1) EP0572190B1 (pt)
JP (1) JP2811036B2 (pt)
KR (1) KR100260061B1 (pt)
CN (1) CN1053807C (pt)
AT (1) ATE169815T1 (pt)
CA (1) CA2096902A1 (pt)
DE (1) DE69320405T2 (pt)
DK (1) DK0572190T3 (pt)
ES (1) ES2121948T3 (pt)
TW (1) TW266154B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
US20020173547A1 (en) 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
EP0708646A1 (en) * 1994-05-06 1996-05-01 Alcon Laboratories, Inc. Use of vitamin e tocopheryl derivatives in ophthalmic compositions
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US5811453A (en) 1994-12-23 1998-09-22 Alcon Laboratories, Inc. Viscoelastic compositions and methods of use
US5798356A (en) * 1995-08-07 1998-08-25 Alcon Laboratories, Inc. Angiostatic compounds
JPH09124484A (ja) * 1995-10-27 1997-05-13 Schering Purau Kk 点眼剤
US6379688B2 (en) 1997-02-28 2002-04-30 Senju Pharmaceutical Co., Ltd. Preservative for emulsion and emulsion containing same
ES2180976T3 (es) * 1997-04-25 2003-02-16 Schering Plough Kabushiki Kais Colirio conteniendo un metabolito de loratidina.
US6226118B1 (en) 1997-06-18 2001-05-01 Olympus Optical Co., Ltd. Optical microscope
US6906858B2 (en) 2000-07-17 2005-06-14 Olympus Optical Co., Ltd. Microscope provided with an objective lens focusing apparatus and an objective lens switching apparatus
US7989503B2 (en) * 2002-05-22 2011-08-02 Nihon Pharmaceutical Co., Ltd. Smooth muscle peristole inhibitor
JP4789479B2 (ja) * 2004-02-23 2011-10-12 ロート製薬株式会社 プラノプロフェン含有水性組成物
DE102004045622A1 (de) * 2004-09-17 2006-03-30 Aquanova German Solubilisate Technologies (Agt) Gmbh Konservierungsmittel-Zusammensetzungen
US9993558B2 (en) * 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
ATE443998T1 (de) * 2006-03-07 2009-10-15 Aquanova Ag Solubilisate von konservierungsmitteln sowie verfahren zu ihrer herstellung
US20080015250A1 (en) * 2006-06-27 2008-01-17 Friedlaender Mitchell H Ultraviolet absorbing ophthalmic compositions
CN101278908B (zh) * 2008-05-18 2010-10-13 程浩文 一种左氧氟沙星滴眼液
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
ES2385995B2 (es) * 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2306684A1 (fr) * 1975-04-11 1976-11-05 Crinex Lab Nouvelle composition a action immunostimulante
JPS60246695A (ja) * 1984-05-22 1985-12-06 松下電器産業株式会社 印刷配線板の製造方法
JPH0737381B2 (ja) * 1987-05-15 1995-04-26 参天製薬株式会社 ビタミンｅ水性製剤
CA1333360C (en) * 1987-10-19 1994-12-06 Andrew S. Janoff Tocopherol-based pharmaceutical systems
JPH01106018A (ja) * 1987-10-20 1989-04-24 Asahi Glass Co Ltd 液晶表示素子

Also Published As

Publication number Publication date
CA2096902A1 (en) 1993-11-27
CN1053807C (zh) 2000-06-28
TW266154B (pt) 1995-12-21
KR940005269A (ko) 1994-03-21
JP2811036B2 (ja) 1998-10-15
DE69320405D1 (de) 1998-09-24
JPH0640910A (ja) 1994-02-15
EP0572190A1 (en) 1993-12-01
ATE169815T1 (de) 1998-09-15
DE69320405T2 (de) 1999-01-14
CN1085082A (zh) 1994-04-13
ES2121948T3 (es) 1998-12-16
EP0572190B1 (en) 1998-08-19
US5559157A (en) 1996-09-24
KR100260061B1 (en) 2000-07-01

Similar Documents

Publication Publication Date Title
DK0572190T3 (da) Oftalmiske præparater indeholdende vitamin E eller en ester deraf som en aktiv ingrediens
ES539266A0 (es) Un procedimiento para la preparacion de nuevas-n-heterociclil-4-piperidinaminas.
AU4438489A (en) Pharmaceutical compositions containing n-(3,4- dimethoxycinnamoyl)anthranilic acid
DK0427247T3 (da) Lægemiddel indeholdende R-alpha- lipoinsyre eller S-alphalipoinsyre som aktiv bestanddel
NO975962L (no) Legemiddelpreparat som omfatter albumin som aktiv bestanddel
ES2131373T3 (es) Composicion oftalmica para prevenir o tratar el ojo seco o una enfermedad causada por el mismo, que comprende acido 12-sulfodeshidroabietico.
PT630252E (pt) Preparacao farmaceutica baseada em ramnolipido contra doencas dermatologicas
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
FI893701A (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
WO1995034302A3 (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
KR950702422A (ko) (에스)-티몰롤 헤미하이드레이트를 함유하는 안약 국소 조성물(ophthalmic topical composition containing (s)-timolol hemihydrate)
AU7424394A (en) 3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
AU4397197A (en) Subepithelial turbidity inhibitor
AU4519189A (en) Medicaments for the treatment of toxoplasmosis
DE69021525D1 (de) Pyrrolaldehydderivate.
SE8001981L (sv) Kompositioner for behandling av glaukom
AR247095A1 (es) Composicion limpida, acuosa, estable en estante, para el tenido del cabello humano.
DE3168004D1 (en) Ophthalmic composition of 5-fluoro-2-methyl-1-(p-methylthio-benzylidene)-3-indenylacetic acid or salt thereof
SE8704712L (sv) Norfenefrininnehallande, farmaceutiska kompositioner
DE69113675D1 (de) Verwendung von Naproxen als Mydriatikum.
KR880012228A (ko) 천식 치료제